News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
The AACR Hematologic Malignancies Research Fellowship
AACR/LinkedIn
Jan 20, 2025, 16:07

The AACR Hematologic Malignancies Research Fellowship

American Association for Cancer Research (AACR) shared a post on LinkedIn:

“The AACR Hematologic Malignancies Research Fellowship is a two-year, $130,000 grant to support a fellow conducting basic, translational, clinical, or population sciences research projects related to hematologic malignancies.

Apply by January 21.”

AACR American Association for Cancer Research cancer hematologic malignancies OncoDaily Oncology research fellowship
Special Coverage
Insight
Jan 20, 2025, 16:07
The AACR Hematologic Malignancies Research Fellowship
Science
Jan 20, 2025, 16:03
Amy Moore: Biomarker testing can help identify actionable mutations in patients with squamous NSCLC
Insight
Jan 20, 2025, 16:03
Navneet Singh: Ensuring global access to the 3 'A's of treatment
Blog
Jan 20, 2025, 15:56
Erman Akkus: Downstaging of HCC before liver transplantation
Blog
Jan 20, 2025, 15:45
Chris Weight: Accepting applications for the Cleveland Clinic Urology, Society of Urologic Oncology fellowship program
Blog
Jan 20, 2025, 15:41
Endoscopic Ultrasound Gastroenterostomy versus Duodenal Stenting for Malignant GOO
Science
Jan 20, 2025, 15:25
Tony Hung: A virtual integrative medicine program to improve symptoms and decrease hospitalization
Blog
Jan 20, 2025, 14:46
Gregg Margolis: Three things to read about health policy this week
Blog
Jan 20, 2025, 14:43
Afreen Shariff: Excellent to connect with fellow board members at the ACCC
Dialogues
Jan 20, 2025, 14:32
The Current Situation with Colorectal Cancer in Kazakhstan
Science
Jan 20, 2025, 14:17
Hung Trinh: Bispecific Antibodies in Cancer Therapy
Insight
Jan 20, 2025, 14:16
Amy Moore: Ensuring that all patients benefit from recent scientific advances in lung cancer